2022 HRO and Safety Education Series - An overview of approaches to cause analysis
Presenters will share their processes for triaging and prioritizing safety events for analysis including near misses or no harm events with a high potential for harm or falls or medication events that are higher volume and aggreging causes would be beneficial.
1. Describe how cause analyses (root, apparent, and aggregating) function together to prevent recurrence of loss events, specifically patient harm events.
2. Apply the five elements of an apparent cause analysis.
3. Explain how capturing the causal data of the apparent cause analyses enables efficient aggregating analysis.
4. Discuss the value of contributing and non-contributing factors along with latent failures in improving patient safety.
Identification, Mitigation, and Disclosure of Relevant Financial Relationships
As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months.
Ineligible companies – those companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.
FDA Off-Label Use
Faculty presenters are also expected to disclose any discussion of (1) off-label or investigational uses of FDA approved commercial products or devices or (2) products or devices not yet approved in the United States.
Absence of Relevant Financial Relationships
The following planners, faculty, and others in control of educational content have no relevant financial relationships with ineligible companies.
Planning committee members
Ellen Flynn, RN, MBA, JD, CPPS
Tammy Williams, MSN, RN, CPPS
Laura Hoffman, DNP, RN, CPHQ
Katy Merkeley, RN, MHSA, PMP, CPPS
Jim Lichauer, Pharm.D., BCPS, FASHP
Project Manager, PI Collaboratives & Advisory - Pharmacy
Jay Prystowsky, MD, MBA
Principal, Operations & Quality
Craig Clapper, PE
Sumita Markan-Aurora, MBBS, MHA
System Director Patient Safety and Clinical Outcomes
Chellie Butel, RN BSN, JD, MHA
System Director Patient Safety
Donald Krohn, MA, MBA
Performance Improvement/Project Management, Operational Excellence and Transformation Support, Center for Clinical Excellence
Joint Accreditation Statement:
In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
This activity is designated for 1.00 contact hours.
Vizient, Inc. is approved by the California Board of Registered Nursing, Provider Number CEP12580, for 1.00 contact hours.
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours.
Universal Activity Number: JA0006103-0000-22-003-L05-P
Vizient, Inc. designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Vizient, Inc. will award CEUs to each participant who successfully completes this program. The CEU is a nationally recognized unit of measure for continuing education and training programs that meet certain criteria (1 contact hour = 0.1 CEU).
- 1.00 ACPE Pharmacist
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 CBRN
- 1.00 General CE – Attendance